Literature DB >> 2831279

Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells.

A Suzumura1, E Lavi, S Bhat, D Murasko, S R Weiss, D H Silberberg.   

Abstract

Neurotropic coronavirus (mouse hepatitis virus strain A59) infection induces major histocompatibility complex class I (H-2) surface antigens on oligodendrocytes and astrocytes, cells that do not normally express detectable MHC antigens on their surface. The induction on MHC antigen expression potentially allows immunocytes to interact with infected glial cells and may play a critical role in the development of virus-induced, immune-mediated demyelination in the central nervous system, a possible model of human multiple sclerosis. In this study, we characterized the soluble factor involved in MHC antigen induction, quantitated induction of MHC antigens, and analyzed the central nervous system cell type involved in the production of the factor. The H-2-inducing factor, most likely produced by astrocytes, was found to be nondialyzable, heat- and trypsin-sensitive, but resistant to treatment at pH 2.0. The m.w. of the factor was estimated as 50 to 100 kDa. Studies on fractionation by ultrafiltration and sucrose density gradient along with antibody-blocking experiments indicate that the factor is not interferon or virus particles.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831279

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus.

Authors:  A P Lieberman; P M Pitha; H S Shin; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus.

Authors:  J Das Sarma; L Fu; J C Tsai; S R Weiss; E Lavi
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  A mechanism of virus-induced demyelination.

Authors:  Jayasri Das Sarma
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-21

4.  Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.

Authors:  Paul T Massa; Stacie L Ropka; Sucharita Saha; Karen L Fecenko; Kathryn L Beuler
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

5.  Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo.

Authors:  B D Pearce; M V Hobbs; T S McGraw; M J Buchmeier
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia.

Authors:  Yun Li; Li Fu; Donna M Gonzales; Ehud Lavi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Primary demyelination in transgenic mice expressing interferon-gamma.

Authors:  Marc S Horwitz; Claire F Evans; Dorian B Mcgavern; Moses Rodriguez; Michael B A Oldstone
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

8.  Coronavirus induction of class I major histocompatibility complex expression in murine astrocytes is virus strain specific.

Authors:  W Gilmore; J Correale; L P Weiner
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

9.  Different mechanisms of inflammation induced in virus and autoimmune-mediated models of multiple sclerosis in C57BL6 mice.

Authors:  Abhinoy Kishore; Anurag Kanaujia; Soma Nag; A M Rostami; Lawrence C Kenyon; Kenneth S Shindler; Jayasri Das Sarma
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411

10.  Flavivirus induces MHC antigen on human myoblasts: a model of autoimmune myositis?

Authors:  S Bao; N J King; C G Dos Remedios
Journal:  Muscle Nerve       Date:  1992-11       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.